Carnegie Healthcare Seminar,
Jefferies Biotech on the Bay Summit,
Contact:
Tel: +46 76 403 35 43
Email: asa.hillsten@calliditas.com
(C) 2024 Electronic News Publishing, source
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
208.1 SEK | -0.05% | +83.10% | +63.65% |
May. 31 | Citigroup Downgrades Calliditas Therapeutics to Neutral From Buy, Price Target at $39 | MT |
May. 31 | Calliditas Partner Secures European Panel Backing for Rare Kidney Disease Treatment | MT |
Carnegie Healthcare Seminar,
Jefferies Biotech on the Bay Summit,
Contact:
Tel: +46 76 403 35 43
Email: asa.hillsten@calliditas.com
(C) 2024 Electronic News Publishing, source
1st Jan change | Capi. | |
---|---|---|
+63.65% | 1.06B | |
+16.38% | 78.51B | |
+13.10% | 9B | |
+58.17% | 4.96B | |
-14.94% | 4.84B | |
-.--% | 3.72B | |
+19.83% | 2.48B | |
-26.63% | 2.19B | |
+16.75% | 2.12B | |
-37.97% | 1.94B |